Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy
Author:
Qiao Guoliang,
Ilagan Crisanta H.,
Fernandez-del Castillo Carlos,
Ferrone Cristina R.,
Janseen Quisette P.,
Balachandran Vinod P.,
Sell Naomi M.ORCID,
Drebin Jeffrey A.,
Hank Thomas,
Kingham T. Peter,
D’Angelica Michael I.,
Jarnagin William R.,
Lillemoe Keith D.,
Wei Alice C.,
Qadan MotazORCID